New Mexico
Register / Volume XXXV, Issue 20 / October 22, 2024
This
is an amendment to 16.2.18 NMAC, Section 8, 9, 12, 13, 15, 19, 20, 24 and 25 effective
10/22/2024.
16.2.18.8 GENERAL
REQUIREMENTS FOR EDUCATIONAL COURSE APPROVAL: The board shall approve an educational course
for a specific category of expanded practice upon completion of the following
general requirements and the specific requirements listed for the specific
category of expanded practice educational course approval. All courses, with the exception of basic injection
therapy, shall adhere to ICE or NCCA credentialing standards. All references to application in this section
refer to the educational course application.
A. The educational course shall provide
at least the minimum number of hours of education in the areas listed for the
specific category of educational course hours.
One hour of education shall be equal to that defined by the
accreditation commission for acupuncture and herbal medicine (ACAHM). The education shall be in addition to the
education required to meet the minimum educational program requirements for
licensure as a doctor of oriental medicine.
B. The educational course application
shall include a description of the education being provided as required by the
educational course general curriculum defined in 16.2.18.11 NMAC and the
educational course curriculum defined for the specific category of expanded
practice for which the educational course is applying for approval.
C. The educational course application
shall include the curriculum vitae for all teachers, and proposed substitute
teachers all classes shall be taught by qualified teachers approved by the
board, provided the following conditions are met:
(1) the education in the pharmacology of
the authorized substances shall be taught by a licensed pharmacist, Pharm D or
a Ph.D. in pharmacology; and
(2) the education in the clinical
therapeutic use of the authorized substances shall be taught by a licensed
health care practitioner with appropriate training and a minimum of five years experience using the authorized substances.
D. The educational course application
shall include documentation that all required clinical practice hours shall
have a teacher to student ratio of at least one teacher to no more than eight
students.
E. The educational course application
shall include examples of the test questions that students enrolled in the
course are required to successfully pass in order to ensure competence in all
required areas. Testing methodology shall be approved by the board and with
the exception of basic injection therapy, the testing shall be
administered, subject to approval by a credentialed PhD psychometrician, as
described in the ICE or NCCA credentialing standards and as approved by
the board. The educational course shall
send all student test scores and evaluation scores directly to the board.
F. The educational course application
shall include an example of the certificate that shall be given for successful
completion of the educational course.
G. Each educational course shall be
completed within two years of commencement of that course.
H. A student who is allergic or
hypersensitive to an authorized substance may be excused from participating in
clinical practice when such an authorized substance is being used.
I. A board member or an agent of the
board has the authority to observe, audit and evaluate
educational courses at any time after an application has been filed. A course audit or evaluation may result in
denial, suspension or revocation of the course’s approval by the board in
accordance with law.
J. The educational course provider
shall specify whether the organization offering the educational course is a
sole proprietorship, partnership, LLC, corporation or non-profit corporation
and shall provide proof of such legal business status.
K. An educational course shall submit a
new application on the form approved by the board, pay the appropriate fee
defined in 16.2.10 NMAC and comply with all other new application requirements
if any of the following changes:
(1) ownership;
(2) faculty; and
(3) curriculum.
L. An educational course shall inform
the board in writing, provided that the educational course certifies that all
factors defined in Subsection J of 16.2.18.8 NMAC remain unchanged, if any of
the following changes:
(1) name;
(2) address; and
(3) phone
number.
[16.2.18.8 NMAC - Rp,
16.2.18.7 NMAC, 6/16/2015; A, 4/25/2023; A, 10/22/2024]
16.2.18.9 EDUCATIONAL
COURSE APPROVAL BOARD REQUIREMENTS:
A. The board shall have final authority
for approval of all educational courses including classes and teachers.
B. The board shall notify the applicant
in writing by mail postmarked no more than 75 days after the receipt of the
initial application as to whether the application is complete or if not
complete, what documentation is needed to complete the application.
C. If the requested information is not
received at the board office within [seventy five (75)] 75 days
after notification the board shall notify the applicant in
writing by mail that the application has expired.
D. Teaching must commence for an
approved course within six [(6)] months of approval.
[E. In the interim between regular board
meetings the expanded practice Rx committee or an authorized representative of
the board shall issue an interim temporary educational course approval to a
qualified applicant who has filed, with the board, a complete application and
complied with all requirements for educational course approval. The interim temporary educational course
approval shall automatically expire on the date of the next regular board
meeting and final educational course approval shall only be granted by the
board. If the application is denied, the
notice of denial shall state the reason the application was denied.
F.] E. If the
application is expired or is denied, the applicant will have to reapply as a
new applicant.
[16.2.18.9 NMAC - Rp,
16.2.18.8 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.12 BASIC
INJECTION THERAPY EDUCATIONAL COURSE APPROVAL: The board shall approve a basic injection
therapy educational course after the educational course provider submits to the
board:
A. [the] a completed
application [form provided by the board];
B. the payment of the application fee
for expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation of having complied
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the basic injection therapy educational course hours defined in
16.2.18.13 NMAC; and
F. documentation demonstrating that it
will provide the basic injection therapy educational course curriculum defined
in 16.2.18.14 NMAC; and
G. [documentation demonstrating that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician, as described in the ICE credentialing standards.] A
passing grade of seventy [(70)] percent is required for certification to
demonstrate learned knowledge.
[16.2.18.12 NMAC - Rp,
16.2.18.11 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.13 BASIC INJECTION THERAPY EDUCATIONAL
COURSE HOURS: The education offered
shall consist of a minimum total of [fifty-eight (58)] 58 contact hours with at least the minimum number of
hours of education in the areas listed below:
A. eight [(8)] hours in
pharmacology and biomedical differential diagnosis relative to the
prescription, administration, compounding and dispensing of the authorized
substances in the basic injection therapy formulary including homeopathic
medicines;
B. two [(2)] hours in the
drawing and compounding of the authorized substances intended for injection in
compliance with USP 797, utilizing approved aseptic technique and proper record
keeping and, storage and dispensing of substances; at least half of the
required hours shall be clinical practice;
C. [fourteen (14)] 14
hours in orthopedic and neurological evaluation; at least half of these
required hours shall be clinical practice;
D. two [(2)] hours in the theory
and practice of vapocoolant spray and stretch techniques using the authorized
vapocoolants; at least half of these required hours shall be clinical practice;
E. [twenty-eight (28)] 28
hours in the theory and practice of injection therapy including: [eleven
(11)] 11 hours of trigger point therapy and injection of acupuncture
points; [eleven (11)] 11 hours of basic mesotherapy; six [(6)]
hours of basic neural therapy, and therapeutic injections (vitamins), using the
authorized substances in the basic injection therapy formulary; at least half
of these required hours shall be clinical practice;
F. one [(1)] hour in
pharmaceutical law as provided by the New Mexico board of pharmacy;
G. one [(1)] in oriental
medicine scope of practice relative to the authorized substances and
techniques; and
H. a minimum of two [(2)] hours
in the use of inhaled oxygen O2 and IM epinephrine for emergency use.
[16.2.18.13 NMAC - Rp,
16.2.18.12 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.15 INJECTION THERAPY EDUCATIONAL
COURSE APPROVAL: The board shall approve an injection therapy
educational program requirements:
A. [the] a completed
application [form provided by the board];
B. payment of the application fee for
expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation that it will comply
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the injection therapy educational course hours defined in
16.2.18.17 NMAC;
F. documentation demonstrating that it
will provide the injection therapy educational course curriculum defined in
16.2.18.18 NMAC; and
G. documentation demonstrating that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician as described in the ICE credentialing standards. A passing grade of seventy (70) percent is
required for certification to demonstrate learned knowledge.
[16.2.18.15 NMAC - Rp,
16.2.18.14 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.19 INTRAVENOUS THERAPY EDUCATIONAL
COURSE APPROVAL REQUIREMENTS FOR CERTIFICATION: The board
will approve an intravenous therapy educational course for certification after
the educational course provider submits to the board:
A. [the] a completed
application [form provided by the board];
B. the payment of the application fee
for expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation of having complied
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.10
NMAC;
E. documentation demonstrating that it
will provide the intravenous therapy educational course hours defined in
16.2.18.20 NMAC;
F. documentation demonstrating that it
will provide the intravenous therapy educational course curriculum defined in
16.2.18.21 NMAC; and
G. documentation that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician, as described in the ICE credentialing standards. A passing
grade of [70] seventy percent is required for certification to
demonstrate learned knowledge.
[16.2.18.19 NMAC - N,
6/16/2015; A, 10/22/2024]
16.2.18.20 INTRAVENOUS THERAPY COURSE
PREREQUISITES: Only a New Mexico licensed DOM, in good standing, and board certified
in basic injection therapy, may apply for an intravenous therapy educational
course in expanded practice.
A. Proof of current BLS/CPR
certification that will be current for two [(2)] years from an American
heart association, American red cross, or American safety and health
institute provider.
B. Proof of completion
of at least three [(3)] semester hours of college level biochemistry
from an accredited institution that provides evaluation of competencies by
examination. A board approved college
level on line course is acceptable.
[16.2.18.20 NMAC - N, 6/16/2015; A, 10/22/2024]
16.2.18.24 BIOIDENTICAL HORMONE THERAPY
EDUCATIONAL COURSE APPROVAL: The
board shall have final authority for approval of a bioidentical hormone
educational program upon completion of the following requirements. The
educational course shall submit to the board:
A. [the] a completed
application [form provided by the board];
B. payment of the application fee for
expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation that it will comply
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the bioidentical hormone therapy educational course hours defined
in 16.2.18.25 NMAC;
F. documentation demonstrating that it
will provide the bioidentical hormone therapy educational course curriculum
defined in 16.2.18.26 NMAC; and
G. documentation demonstrating that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician, as described in the ICE credentialing standards. A passing grade of seventy [(70)] seventy
percent is required for certification to demonstrate learned knowledge.
[16.2.18.24 NMAC - Rp,
16.2.18.19 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.25 BIOIDENTICAL
HORMONE THERAPY EDUCATIONAL COURSE HOURS: The bioidentical hormone
educational course shall consist of a minimum total of [eighty (80)] 80
hours of education, with at least [twenty four (24)] 24 hours of
practical experience defined in Subsections B, C, D, E and F of
16.2.18.25 NMAC in the areas listed below:
A. eight [(8)] hours in the
pharmacology of bioidentical hormones;
B. [eighteen (18)] 18
hours in an overview of the endocrine system, including the anatomy and
interactive physiology of the hypothalamic-pituitary-adrenal-thyroid (HPAT) and
gonadal axis, the stress response and normal adrenal and thyroid function; also
to include normal male and female sex hormone physiology; at least half of
these hours shall be in practice or review of case studies;
C. [twenty (20)] 20 hours
in theory and practice of endocrinology including evaluation and treatment of
the patient with hormonal dysfunction and imbalances including but not limited
to; adrenal fatigue, auto-immune endocrine disorders, hypothyroid,
hyperthyroid, men’s hormone imbalances and women’s hormonal imbalances pre,
peri and post menopause and consideration and assessment for treatment with
bio-identical hormone replacement therapy, BHRT; at least half of these hours
will be in practice or review of case studies;
D. [fourteen (14)] 14
hours in blood chemistry analysis including but not limited to; CBC, CMP, LFT,
lipids, ferritin, homocysteine, vitamin D, iodine, hs
CRP, fibrinogen, ANA, ESR, HgBAIC, insulin
antibodies;
E. two [(2)] hours in urine
analysis;
F. [sixteen (16)] 16
hours in the assessment and treatment of hormone and neurotransmitter imbalances through blood, urine and saliva
hormone testing and evaluation; appropriate treatment options for the
biomedical differential diagnoses including, but not limited to; adrenal
fatigue, thyroid imbalances, andropause, menopausal syndrome, and other male
and female hormone imbalances; at least half of these hours shall be in
practice or case study review;
G. one [(1)] hour in
pharmaceutical law as provided by the New Mexico board of pharmacy; and
H. one [(1)] hour in oriental
medicine scope of practice relative to the prescription or administration of
the authorized substances.
[16.2.18.25 NMAC - Rp,
16.2.18.20 NMAC, 6/16/2015; A, 10/22/2024]